Biomedical Sciences你了解多少?
时间:2022-05-19 10:07:04 栏目:留学资讯The course
Gain a thorough grounding in the basis, prevention, diagnosis and treatment of disease by studying Biomedical Sciences at Royal Holloway, University of London.
This comprehensive programme will prepare you to join the ranks of biomedical researchers at the forefront of human health investigation. You’ll study biochemistry, physiology, cell biology, molecular biology and genetics before choosing from a range of optional modules in years 2 and 3, allowing you to specialise and follow your own particular interests.
As a 2nd and 3rd-year student, you’ll receive specialist teaching from local health professionals, allowing you to learn more about subjects including neuroscience and clinical diagnosis of disease. You’ll have the option to embark on a lab-based individual research project in your 3rd year, joining a renowned research culture that has seen former students contribute to published scientific papers.
You’ll benefit from a recent £16 million investment in state-of-the-art equipment for bioinformatics, mass spectrometry and protein and gene sequencing, as well as our excellent imaging facilities, including confocal laser scanning microscopes for 3D live-cell imaging.
Through your studies you will gain an impressive portfolio of transferable skills, making you an attractive prospect for potential employers. Invaluable lab experience, specialist learning and communication skills will help you to join our alumni in sectors including medical research, biotechnology and clinical trials coordination.
- Explore the function and integration of selected human physiological systems in normal physiology and disease.
- Become familiar with molecular biology techniques.
- Develop an understanding of the theory, technology, and clinical practice of human molecular genetics.
- Carry out an individual laboratory or theoretical investigation under supervision.
版权声明:
1、本文系转载,版权归原作者所有,旨在传递信息,不代表看本站的观点和立场。
2、本站仅提供信息发布平台,不承担相关法律责任。
3、若侵犯您的版权或隐私,请联系本站管理员删除。
4、、文章来源:https://www.dir20.com/news/16813.html